New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
11:51 EDTLL, SRPT, OREX, MBI, FTNT, INFN, STX, AVP, GNCOptions with increasing implied volatility:
Options with increasing implied volatility: LL SRPT OREX MBI FTNT INFN STX AVP GNC
News For LL;SRPT;OREX;MBI;FTNT;INFN;STX;AVP;GNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
October 22, 2014
09:24 EDTFTNTFortinet to host conference call
Subscribe for More Information
09:21 EDTLLLumber Liquidators drops after earnings and guidance, levels to watch
Subscribe for More Information
09:21 EDTLLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Dow Chemical (DOW), up 3.7%... iRobot (IRBT), up 12%... Six Flags (SIX), up 13%... GlaxoSmithKline (GSK), up 2%... Broadcom (BRCM), up 7%... Boston Scientific (BSX), up 4.3%... Abbott (ABT), up 1.8%... Yahoo! (YHOO), up 6%. ALSO HIGHER: Blue Earth (BBLU), up 26.4% after CEO says statements in Seeking Alpha blog are "false and misleading."... GW Pharmaceuticals (GWPH), up 5.4% after Epidiolex receives orphan designation from EMA. DOWN AFTER EARNINGS: 3D Systems (DDD), down 15%... Biogen (BIIB), down 7%... Lumber Liquidators (LL), down 13.4%... Norfolk Southern (NSC), down 3%... Angie's List (ANGI), down 8.8%. ALSO LOWER: Nanosphere (NSPH), down 33% after filing secondary, reporting preliminary Q3 revenue... Himax Technologies (HIMX), down 16% after announcing that Google (GOOG) will not exercise an additional investment option in the company... Cree (CREE), down 10.5%, downgraded at DA Davidson and Canaccord following the company's Q1 earnings results... Ocwen Financial (OCN), down 7% after downgraded to Hold at Evercore, downgraded to Neutral at BofA Merrill Lynch... VMware (VMW), down 7.8%, downgraded at Nomura and Raymond James following the company's Q3 results.
07:14 EDTLLLumber Liquidators reports Q3 comparable store sales down 4.9%
Subscribe for More Information
07:04 EDTLLLumber Liquidators sees Q4 EPS 71c-85c, consensus 89c
Subscribe for More Information
07:03 EDTLLLumber Liquidators cuts FY14 EPS to $2.38-$2.52 from $2.65-$3.00
Subscribe for More Information
07:01 EDTLLLumber Liquidators reports Q3 EPS 58c, consensus 68c
Subscribe for More Information
06:44 EDTFTNTU.S. weighing cybersecurity requirements for bank vendors, NY Times says
Subscribe for More Information
06:41 EDTSRPTWHO fast-tracking testing of two Ebola vaccines, Guardian reports
Subscribe for More Information
October 21, 2014
10:53 EDTLLExact Sciences, Lumber Liquidators shorts recomended by Tilson, Bloomberg says
Kase Capital's Whitney Tilson recommended short positions in Exact Sciences (EXAS) and Lumber Liquidators (LL) while speaking at the Robin Hood Conference, according to Bloomberg.
09:12 EDTGNCGNC, eBay, Vivendi recommended as long ideas by Sandler, Bloomberg reports
Subscribe for More Information
October 20, 2014
14:46 EDTGNCVitamin Shoppe may hire adviser amid pressure for deal, Reuters says
Vitamin Shoppe (VSI), which has been urged by activist shareholders to consider a sale, is speaking to banks and may hire a financial adviser, according to Reuters, citing people familiar with the matter. Note that Reuters previously reported on September 18 that some large Vitamin Shoppe holders have urged the company to consider a sale to rival GNC Holdings (GNC) or to a private equity buyer. That same day, The Financial Times reported that GNC was considering a possible sale after receiving attention from private equity suitors. Following this latest report from Reuters, shares of Vitamin Shoppe are up 6.7% to $45.23 in afternoon trading, while GNC shares are up over 3% to $38.88. Reference Link
09:36 EDTINFNActive equity options trading on open
Subscribe for More Information
09:09 EDTSRPTEMA encourages applications for orphan designation for Ebola treatments
The European Medicines Agency encourages developers of treatments or vaccines against Ebola to apply for orphan designation. Applications for orphan designation of Ebola medicines will be treated as a priority and EMA has committed to fast-tracking their evaluation, the regulator announced. Drug companies that are working on experimental Ebola vaccines and treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX), NewLink Genetics (NLNK) and GlaxoSmithKline (GSK).
08:08 EDTOREXOrexigen and Takeda announce availability of Contrave tablets for patients
Takeda Pharmaceutical, its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A. and Orexigen Therapeutics jointly announced that Contrave extended-release tablets are now available to patients by prescription in pharmacies across the U.S.. Contrave is approved by the FDA as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater, or 27 kg/m2 or greater in the presence of at least one weight-related comorbid condition.
October 19, 2014
16:44 EDTSRPTEbola drug discovery efforts intensify, WSJ says
Subscribe for More Information
13:39 EDTSRPTCarnival cruise passenger tests negative for Ebola, Reuters says
Subscribe for More Information
October 17, 2014
14:50 EDTSRPTBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
09:46 EDTSRPTSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
09:17 EDTSRPTOn The Fly: Pre-market Movers
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use